Education
About Us
Working with TipRanks
Follow Us
DRI Healthcare (TSE:DHT.UN)
TSX:DHT.UN
DHT.UN Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$10.39 - C$17.12
Previous CloseN/A
Volume18.32K
Average Volume (3M)33.97K
Market Cap
C$627.87M
Enterprise ValueC$1.24B
Total Cash (Recent Filing)$62.84M
Total Debt (Recent Filing)$145.48M
Price to Earnings (P/E)41.1
Beta-0.21
Next Earnings
May 12, 2025EPS Estimate
0.74Last Dividend Ex-Date
Mar 31, 2025Dividend Yield4.42%
Share Statistics
EPS (TTM)-0.07
Shares Outstanding56,310,920
10 Day Avg. Volume41,414
30 Day Avg. Volume33,965
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.97
Price to Cash Flow (P/CF)3.00
P/FCF Ratio1.90
Enterprise Value/Market Cap1.97
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.94
Enterprise Value/Ebitda19.57
Forecast
1Y Price Target
C$16.67Price Target Upside49.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
Bulls Say, Bears Say
Bulls Say
Governance ImprovementDHT has improved its governance structure by requiring independent trustees to take at least half their retainer in equity, aligning interests with shareholders.
Innovative AcquisitionDHT has announced the acquisition of certain payment rights tied to CASGEVY, which is a novel deal structure for the company.
Management ConfidenceAli Hedayat, with extensive experience from Goldman Sachs and hedge funds, is involved in DHT's strategy and owns shares personally, indicating confidence in the company's direction.
Bears Say
Auditing IssuesThere are gaps in DHT's auditing process, with speculation that Deloitte was not effectively sampling invoices for audit.
Auditing ProcessThere are gaps in DHT's auditing process, with speculation that Deloitte was not effectively sampling invoices for audit.
Fraudulent ChargesDHT has faced fraudulent consulting charges put through by Behzad Khosrowshahi, with capital siphoned into his personal account.
---
Options Prices
Currently, No data available
---
Ownership Overview
8.34% Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
91.56% Public Companies and
Individual Investors
DHT.UN FAQ
What was DRI Healthcare’s price range in the past 12 months?
DRI Healthcare lowest stock price was C$10.39 and its highest was C$17.12 in the past 12 months.
What is DRI Healthcare’s market cap?
DRI Healthcare’s market cap is C$627.87M.
When is DRI Healthcare’s upcoming earnings report date?
DRI Healthcare’s upcoming earnings report date is May 12, 2025 which is in 19 days.
How were DRI Healthcare’s earnings last quarter?
DRI Healthcare released its earnings results on Mar 03, 2025. The company reported C$1.102 earnings per share for the quarter, beating the consensus estimate of C$0.749 by C$0.353.
Is DRI Healthcare overvalued?
According to Wall Street analysts DRI Healthcare’s price is currently Undervalued.
Does DRI Healthcare pay dividends?
DRI Healthcare pays a Quarterly dividend of C$0.144 which represents an annual dividend yield of 4.42%. See more information on DRI Healthcare dividends here
What is DRI Healthcare’s EPS estimate?
DRI Healthcare’s EPS estimate is 0.74.
How many shares outstanding does DRI Healthcare have?
DRI Healthcare has 56,310,920 shares outstanding.
What happened to DRI Healthcare’s price movement after its last earnings report?
DRI Healthcare reported an EPS of C$1.102 in its last earnings report, beating expectations of C$0.749. Following the earnings report the stock price went up 5.37%.
Which hedge fund is a major shareholder of DRI Healthcare?
Currently, no hedge funds are holding shares in TSE:DHT.UN
---
DRI Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$16.67 (49.51% Upside)
C$16.67 (49.51% Upside)
Insider Transactions
Bought Shares
Worth C$99.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.90%
12-Months-Change
Fundamentals
Return on Equity
-0.51%
Trailing 12-Months
Asset Growth
28.65%
Trailing 12-Months
Company Description
DRI Healthcare
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
---
DHT.UN Stock 12 Month Forecast
Average Price Target
C$16.67
▲(49.51% Upside)
Technical Analysis
Knight Therapeutics
―
Martinrea International
―
THC Biomed INTL
―
Neo Performance Materials Inc
―
HLS Therapeutics Inc
―
Best Analysts Covering DHT.UN
1 Year
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
-
a rating ―
Copying Douglas Miehm's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of - per trade.
---